[Eur Heart J 2018;39:4112–4121].
In the original version of the above article, there was an error in the middle panel of Figure 3. This has now been corrected online.
The authors apologise for the error.
. 2019 Feb 7;40(15):1201. doi: 10.1093/eurheartj/ehz029
Corrigendum to: Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10 854 patients from the CHAMPION PHOENIX trial
Issue date 2019 Apr 14.
© The Author(s) 2019. Published by Oxford University Press on behalf of the European Society of Cardiology.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
PMCID: PMC6462307 PMID: 30753500
This corrects the article "Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10 854 patients from the CHAMPION PHOENIX trial" in volume 39 on page 4112.